Home
Tarsus Pharmaceuticals

Tarsus Pharmaceuticals Market Share Analysis for August 2026

Interested in a career at Tarsus?

Health > Biotechnology and Pharmaceuticals

Domaintarsusrx.com

Year Founded2017

Employees201 - 500

Annual Revenue$500M - $1B

Tarsus Pharmaceuticals

Tarsus Pharmaceuticals (including company regionals)

tarsusrx.com

See more website traffic and engagement information

Tarsus Pharmaceuticals Revenue up to August 2026 is 500M - 1B

revenue generated by Tarsus Pharmaceuticals top domains

Tarsus Pharmaceuticals top domains revenue over 3 years

Revenue for Tarsus Pharmaceuticals top domains

tarsusrx.com500M - 1B

See more with Sales Intelligence

Total visits to Tarsus Pharmaceuticals's top domains

Understand Tarsus Pharmaceuticals market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

tarsusrx.com31.5K

See more with Sales Intelligence

Avg. visit duration in Tarsus Pharmaceuticals's top domains

Analyze Tarsus Pharmaceuticals engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

tarsusrx.com00:02:05

See more with Sales Intelligence

Avg. pageviews on Tarsus Pharmaceuticals's top domains

See how Tarsus Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

tarsusrx.com2.88

See more with Sales Intelligence

Tarsus Pharmaceuticals top competitors by domain

Top similar sites in August 2026, ranked by their affinity

jnjinnovation.comCompany NameJNJInnovationEmployees201 - 500HQUnited Kingdom, CambridgeAnnual revenue$75M - $100MTotal visits37KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Tarsus Pharmaceuticals

These are the website technologies, by industry, used by Tarsus Pharmaceuticals top domains

Advertising (7)

PubMatic

Conversion & Analytics (4)

Google Analytics

Email Services (4)

G Suite

Social (4)

Instagram

More Technologies

12

See all

News & Signals from Tarsus Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTarsus Pharmaceuticals, Inc. acquired Alkeus Pharmaceuticals, Inc. for $450M on Aug 6th '26.IRVINE, Calif., Sept. 04, 2026 (GLOBE NEWSWIRE) - Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) today announced that it has completed its previously announced acquisition of Alkeus Pharmaceuticals, Inc., a privately held retinal disease-focused biotechnology company.

NewsTarsus Pharmaceuticals, Inc. had revenue of $174M on Jul 1st '26.Tarsus already generates revenues from Xdemvy (lotilaner), used to treat blepharitis (eyelid inflammation) caused by Demodex mites, sales of which grew 69% to $174 million in the second quarter of this year.

NewsTarsusrx will develop IRX-101 on Apr 1st '27.* Tarsus plans to begin a phase 3 study of IRX-101 in the first half of 2027, with results expected in 2028.